Why the study?
What are the outcomes and survival rates following pericardiocentesis for symptomatic malignant pericardial effusion?
Population
36 patients with symptomatic malignant pericardial effusion. Commonest underlying tumors were lung cancer…
Design
Case_series
Follow-up
up to 36 months
Authors
Loading...
Supports sclerotherapy to reduce recurrence after pericardiocentesis; hypothesis-generating for malignant effusion management pending prospective data.
What are the outcomes and survival rates following pericardiocentesis for symptomatic malignant pericardial effusion?
Pericardiocentesis with intrapericardial sclerotherapy provides good local control for malignant pericardial effusions, though overall survival remains poor and is dependent on the primary malignancy.
Celerrnajer et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: